The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Patterson Companies Inc

Nasdaq: PDCO
Last

(U.S.) $42.62

Today's change-0.62 -1.43%
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.
 

Patterson Companies Inc

Nasdaq: PDCO
Last

(U.S.) $42.62

Today's change-0.62 -1.43%
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.

Patterson Companies Inc down (U.S.)$0.62

Patterson Companies Inc closed lower Friday, dropping (U.S.)$0.62 or 1.43% to (U.S.)$42.62. Over the last five days, shares have gained 0.38%, but are down 5.73% for the last year to date. Shares have underperformed the S&P 500 by 8.19% during the last year.

Key company metrics

  • Open(U.S.) $43.15
  • Previous close(U.S.) $43.24
  • High(U.S.) $43.49
  • Low(U.S.) $42.34
  • Bid / Ask-- / --
  • YTD % change-5.73%
  • Volume945,064
  • Average volume (10-day)1,128,775
  • Average volume (1-month)935,965
  • Average volume (3-month)908,101
  • 52-week range(U.S.) $38.51 to (U.S.) $53.07
  • Beta0.88
  • Trailing P/E23.31×
  • P/E 1 year forward17.44×
  • Forward PEG1.75×
  • Indicated annual dividend(U.S.) $0.88
  • Dividend yield2.06%
  • Trailing EPS(U.S.) $1.83
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+3.84%

Based on its net profit margin of 3.84%, Patterson Companies Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.08%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedOct 31, 201510/31/2015Aug 01, 201508/01/2015Apr 25, 201504/25/2015Jan 24, 201501/24/2015
Revenue1,3891,1431,1491,063
Total other revenue--------
Total revenue1,3891,1431,1491,063
Gross profit331288334303
Total cost of revenue1,058855815761
Total operating expense1,3061,0811,042973
Selling / general / administrative--------
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total247226227212
Operating income836210791
Interest income (expense), net non-operating-17-12-8-9
Gain (loss) on sale of assets--------
Other--------
Income before tax67519983
Income after tax43206555
Income tax, total25303528
Net income35306555
Total adjustments to net income--------
Net income before extra. items43206555
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items43206555
Inc. avail. to common incl. extra. items35306555
Diluted net income35306555
Dilution adjustment--00--
Diluted weighted average shares99100100100
Diluted EPS excluding extraordinary itemsvalue per share0.430.200.650.55
Dividends per sharevalue per share0.220.220.220.20
Diluted normalized EPSvalue per share0.430.200.650.55